2022 New Treatment Accelerator Grant Recipients
The New Treatment Accelerator Grants fund projects at any stage (preclinical to clinical) that will significantly accelerate treatments to pancreatic cancer patients,
and grow capacity in pancreatic cancer research in Australia. Grant applications were assessed by our international Scientific Advisory Panel comprised of international and national experts in the field.
The New Treatment Accelerator Grants fund projects at any stage (preclinical to clinical) that will significantly accelerate treatments to pancreatic cancer patients,and grow capacity in pancreatic cancer research in Australia. Grant applications were assessed by our international Scientific Advisory Panel comprised of international and national experts in the field.
Accelerator Grants
Using precision medicine approaches in pancreatic cancer to improve chemosensitivity via porcupine inhibition
Advanced analysis of lipid metabolism in pancreatic cancer to reveal new therapeutic targets
Trapping pancreatic cancer in a crossfire: investigating a combination treatment approach designed to eradicate pancreatic cancer
Targeting epigenetic modifying enzymes as a novel therapy for pancreatic cancer
